Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739410-24-000136
Filing Date
2024-11-07
Accepted
2024-11-07 16:08:32
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rlyb-20240930.htm   iXBRL 10-Q 1218773
2 EX-31.1 rlyb-20240930xex311.htm EX-31.1 10289
3 EX-31.2 rlyb-20240930xex312.htm EX-31.2 10278
4 EX-32.1 rlyb-20240930xex321.htm EX-32.1 4852
5 EX-32.2 rlyb-20240930xex322.htm EX-32.2 4834
11 rlyb-20240930_g1.jpg GRAPHIC 8945
  Complete submission text file 0001739410-24-000136.txt   5341619

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlyb-20240930.xsd EX-101.SCH 30205
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlyb-20240930_cal.xml EX-101.CAL 45630
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlyb-20240930_def.xml EX-101.DEF 172473
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlyb-20240930_lab.xml EX-101.LAB 508472
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlyb-20240930_pre.xml EX-101.PRE 356926
66 EXTRACTED XBRL INSTANCE DOCUMENT rlyb-20240930_htm.xml XML 491457
Mailing Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510
Business Address 234 CHURCH STREET SUITE 1020 NEW HAVEN CT 06510 203- 859-3820
Rallybio Corp (Filer) CIK: 0001739410 (see all company filings)

EIN.: 851083789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40693 | Film No.: 241435657
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)